Cyclosporine A is prescribed for a number of ophthalmic applications such as dry eyes, uveitis in children and adolescents, vernal keratoconjunctivitis, and peripheral ulcerative keratitis. Extended release of cyclosporine from contact lenses has been explored due to the significant benefits of increased bioavailability in comparison with eye drops. Incorporation of drug loaded particles is considered to be a promising approach for increasing the drug release duration. Here we explore the feasibility of extended release of cyclosporine and possibly other hydrophobic drugs by dispersing particles that are 100% drug rather than drug loaded particles. The expected benefits are high drug loading and extended release. Specifically, we explore transport of cyclosporine in hydroxyethyl methacrylate gels for the case when the gel is loaded with high concentration of drug leading to in situ formation of particles. We explore whether we can increase the release duration from the gels by incorporation of the particles, without sacrificing light transmission which is a critical property for contact lenses. Hydrogels were prepared by free radical UV initiated polymerization with drug dissolved in the monomer solution at varying loadings. Drug release kinetics were measured from the particle loaded lenses and fitted to the Higuchi model to determine the diffusivity. The measured diffusivity is two orders of magnitude lower than estimates from Brinkman model. The differences were attributed to the high partition coefficient of about 150, which implies that a majority of the drug in the gel is bound to the polymer. The bound drug can diffuse along the surface or desorb and diffuse. The diffusivity estimates match the measured values after binding is taken into consideration. Light transmittance was measured to determine whether particle incorporation reduces the transparency. Results showed that the drug release duration could be controlled by increasing the drug loading but the transmittance was significantly reduce particularly at high drug loadings, which suggest that this approach may have limited applicability for contact lenses, but could be useful in other applications where light transmission is not critical.
Introduction
Eye drops account for about 90% of all ophthalmic drug formulations in spite of many deficiencies [1] . Low corneal permeability along with the small residence time of eye drops [2] [3] [4] [5] [6] [7] results in a low bioavailability of about 1-5%, with the remaining 95-99% entering systemic circulation through conjunctival uptake or drainage into the nasal cavity [8] . Many approaches have been explored for improving bioavailability including using viscosity enhancers [9, 10] and mucoadhesive polymers [11] , and/or including particles in the formulation such as liposomes, niosomes, microspheres, and microemulsion [12, 13] . Another approach that has received significant attention is to incorporate the drugs in hydrogels that can be placed in the cul de sac or on the cornea in the design of a contact lens. On insertion of a medicated contact lens in the eye, drug diffuses through the lens matrix into the thin tear film named post-lens tear film (POLTF) trapped between the lens and the cornea, and the drug has a residence time about 30 min on the eye [14, 15] . An increase in the residence time leads to a significant increase in the bioavailability. Both mathematical models and clinical data suggest that the bioavailability for ophthalmic drug delivery using contact lenses can be as large as 50% [16] . This work focuses on designing a contact lens to manage the most common ocular disease, dry eyes, by using the currently approved drug, Cyclosporin A (CyA).
CyA is a cyclic polypeptide consisting of 11 amino acids. It is the most commonly used immunosuppressant, and it is prescribed for a number of ophthalmic applications such as dry eyes [17] , uveitis in children and adolescents [18] , vernal keratoconjunctivitis [19] , and peripheral ulcerative keratitis [20] . Due to its limited solubility in water, it is not possible to formulate an aqueous solution of CyA, and thus a variety of novel formulations have been explored including solutions in oil [21, 22] , emulsions [23, 24] , cyclodextrins [25] , surfactants as permeability enhancers [26] or micelles [27] , liposomes [28] , and chitosan particles [29] [30] [31] . RESTASIS®, a formulation based on emulsion is available commercially, and recently another emulsion formulation IKERVIS® was launched in Europe. Many of the systems cited above are promising but suffer from the typical deficiencies of eye drops. Researchers have tried extended release systems for cyclosporine including [32] , puncta plugs [33] and fornix inserts [34] . As discussed earlier, contact lenses can increase the bioavailability of the ocular drugs by increasing the residence time on the ocular surface. Furthermore, cyclosporine release from contact lenses could also be useful for managing contact-lens mediated dry eyes. Researchers have explored extended release of cyclosporine from contacts loaded with self-assembled Brij micelles. The partitioning of cyclosporine into the Brij aggregates was shown to increase the drug release duration [35, 36] . Many other studies have also shown the feasibility of extending release duration by incorporation of drug loaded particles [37, 38] . In most of these studies, the drug loading in the particles was relatively small. For hydrophobic drugs, it may be feasible to load nanoparticles made with 100% drug, rather than particles with small drug loading. Furthermore, this would alleviate the need for excipients that are used in the particle manufacturing, which could potentially show toxicity towards the cornea. Additionally, nanoparticles may degrade during autoclaving and release drug during the long storage. Incorporation of pure drug particles will address these issues as well. Here, we design lenses containing drug particles and explore whether extended release of cyclosporine and possibly other hydrophobic drugs can be achieved by this approach. Our approach is based on the idea that hydrophobic drugs have higher solubility in the monomer mixture compared to the polymerized gel so drug particles can be created in situ by dissolving the drug in the monomer solution at sufficiently high concentration. As the monomer solution polymerizes, the drug solubility decreases leading to phase separation, and formation of particles. This approach is expected to result in high loading and extended release, but there is a potential for decrease in transparency. We want to test whether drug release durations can be increased without sacrificing the clarity of the lens.
Materials and methods

Materials
2-Hydroxyethyl methacrylate (HEMA) monomer, ethylene glycol dimethacrylate (EGDMA), Dulbecco's phosphate buffered saline (PBS), acetonitrile and HPLC grade water were purchased from Sigma-Aldrich Chemicals (St Louis, MO). 2,4,6-trimethylbenzoyl-diphenyl-phophineoxide (TPO) was kindly provided by Ciba (Tarrytown, NY). CyA was purchased from LC Laboratories (Woburg, MA). All the chemicals were reagent grade. Acetonitrile was filtered before use and all the other chemicals were used without further purification.
Methods
2.2.1. Synthesis of drug Laden and pure p-HEMA gels p-HEMA hydrogels were synthesized by free radical solution polymerization of the monomer with chemical initiation [35] [36] [37] [38] . Drug was loaded in the p-HEMA gels by dissolving the drug in the monomer mixture at concentrations ranging from 0.125% to 5.25% (w/dry gel w). Briefly, 2.7 ml of drug loaded HEMA monomer was mixed with 15 μl of the crosslinker (EGDMA) and 2 ml of deionized (DI) water. Water was added to make removal of gel from the molds easier. The volume of water can be reduced if the drug does not dissolve in the mixture. The solution was then degassed by bubbling nitrogen for 10 min. Next, 6 mg of the initiator (TPO) was added, and the solution was stirred at 300 rpm for 10 min to ensure complete solubilization of the initiator. The solution was then poured into a mold comprising two glass plates separated by a polyester spacer having a thickness of 200 μm. The mold was then placed on Ultraviolet transilluminiator UVB-10 (Ultra-Lum, Inc.) and the gel was cured by irradiating UVB light (305 nm) for 40 min. These methods led to successful synthesis of the drug loaded p-HEMA hydrogels.
After polymerization, each gel was removed from the glass mold and was cut into smaller square pieces (1.5 × 1.5 cm, 40 mg) and these gels were dried at room temperature for two days before drug release was initiated. Control gels were synthesized in a similar manner as described above except that the drug was not mixed in the monomer solution before polymerization.
Drug detection
CyA concentration was measured using a HPLC (Waters, Alliance System) equipped with a C18 reverse phase column and a UV detector [39] . The mobile phase composition was 70% acetonitrile and 30% DI water, and the column was maintained at 60°C. The flow rate was fixed at 1.2 ml/min and the detection wavelength was set at 210 nm. The retention time for CyA under these conditions was 4.55 min, and the calibration curve for area under the peak vs. concentration was linear (R 2 = 0.995).
Drug release in non-sink conditions
Studies were conducted in which dynamic drug release was measured without replacing the release medium to determine the partition coefficient of the drug in the p-HEMA matrix. The drug release is expected to stop when the concentration of drug in the release medium and that in the lens are in equilibrium. The release data at equilibrium was used to calculate the partition coefficients for different initial drug loadings. For these experiments, the square gel pieces (1.5 × 1.5 cm, 40 mg) loaded with drug were submerged in 3.5 ml of PBS solution at room temperature. In these experiments only a fraction of the drug diffused out of the gel and equilibrium was established between the concentration in the gel and that in PBS.
In an alternative set of experiments, drug was dissolved in the PBS solution at concentration of 11 μg/ml or 14 μg/ml and uptake of drug was measured in gels. Again, dynamic uptake was recorded for these systems till there was no further uptake of the drug by the gel. For each measurement, only 20 μl of solution was required which was significantly lower than the total fluid volume (3.5 ml) ensuring negligible volume changes during these experiments.
Drug release in sink conditions
Drug release kinetics was also measured by soaking the gel (1.5 × 1.5 cm, 40 mg) in 3.5 ml PBS buffer which was replaced every 24 h to maintain sink conditions. These experiments were conducted till majority of the drug diffused from the gel matrix. PBS change experiments mimicked perfect sink conditions and were used to validate the model for drug release from the particle-loaded p-HEMA hydrogel.
Transmittance measurements
Transparency of drug containing hydrogels was quantified by measuring the transmittance of 200 μm thick hydrated gels at 600 nm using a UV-VIS spectrophotometer (Thermospectronic Genesys 10 UV). Gels were soaked in 3 ml of PBS for a day before the transmittance measurements were made.
SEM images of Cyclosporine A aggregates in p-HEMA hydrogels
Scanning Electron Microscopy (SEM) images were obtained on FEI Nova NanoSEM 430 in the Nanoscale Research Facility (NRF) at the University of Florida, Gainesville. Drug Laden p-HEMA hydrogels were sputter coated with an ultra-thin, 10 nm thick layer of electrically conducting gold-palladium alloy prior high-resolution SEM imaging. This pre-imaging procedure is done to prevent charging of hydrogel samples from accumulation of static electric fields. The synthesized hydrogel specimens were imaged at an accelerating voltage of 10 kV and a magnification range of 2500×-5000×.
Statistical analysis
Linear regression analysis to determine slopes, correlation coefficients and confidence intervals was done in JMP which has been developed by SAS (Cary, North Carolina). Slopes were compared by determining the confidence interval for the respective systems. Fig. 1 shows the drug release profiles from gels loaded with varying drug concentration. The figure also includes results from the uptake studies in which control lenses were soaked in PBS-drug solutions. Results clearly show that the drug uptake profiles (top four curves in the figure) overlap within 95% confidence interval (CI) when the% Uptake is plotted as a function of time. However, the% Release curves clearly do not overlap and in fact the time duration till equilibrium increases with increasing drug loading. If drug release obeys Fickian diffusion than the percentage release of the drug should be independent of the initial drug loading inside the polymer matrix. The deviations at higher loadings are clearly due to the presence of drug particles in the gels.
Results and discussion
Drug release in non-perfect sink
The equilibrium, i.e., the long time data was used to calculate the partition coefficient K (Eq. (1)), i.e., ratio of the concentration in the gel and the concentration in the aqueous phase were calculated from the equilibrium release.
The amount of CyA in the gel phase at equilibrium was calculated by subtracting the content of CyA in PBS phase from the initial loaded content of the drug in the gel matrix. Similarly, for experiments in which uptake of the drug was measured, amount of CyA inside the gel phase was calculated by subtracting the amount left in the solution from the initial drug dissolved. Fig. 2 shows the dependence of partition coefficient on the equilibrium drug concentration in the release medium. Since the partition coefficient of the drug is very large in all the cases, it can be safely concluded that there is significant binding of the drug to the p-HEMA matrix. The data shows that the partition coefficient of the drug between the poly-HEMA matrix and PBS solution is constant till a critical concentration is reached inside the PBS phase which corresponds to the solubility limit of the drug in the PBS buffer. The concentration at which this deviation from a constant partition coefficient takes place should be the solubility limit of CyA (C sol ) in PBS, which is determined to be 20 μM or consequently, 24.05 μg/ml. This value is very close to the solubility limit of CyA in water at room temperature (27.67 μg/ml) [40] . The slightly lower values in PBS are expected because CyA is a hydrophobic molecule, so its solubility decreases with increasing ionic strength. The partition coefficient of the drug is determined to be 148 ± 24.16 for the case when drug concentration in the release medium is less than the solubility limit of the drug. The x-axis in Figure represents the concentration of CyA in the PBS, which cannot exceed the solubility limit. It is possible that CyA loaded in the lens continues to diffuse out and excess drug can then form precipitates in the aqueous phase, but we did not observe this as the concentration in the aqueous phase never exceeds the solubility limit. Since the aqueous concentrations never exceed the solubility limit, the partition coefficient as defined by Eq. (1) starts to increase sharply when the amount of drug loaded into the gels is larger than what can be accommodated in the solution at solubility limit and the gel at the equilibrium concentration. Thus, if the initial mass of the drug in the gel is larger than C sol V f + KC sol V gel , the remaining mass will remain in the gel as particles. At higher loadings, the mass of the drug that remains as particles must be subtracted from the total mass to determine the concentration of the dissolved drug, which should then be used to determine the partition coefficient K.
Modeling drug release under sink conditions
The drug release from a gel loaded with drug placed in a sink is given by the following equation,
Here D is the effective diffusivity of the drug in the gel, h is the half- There is a significant jump in the partition coefficient around 0.02 mM which is the solubility limit of CyA in the PBS buffer.
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thickness of the gel and t is the time of release. The diffusivity of cyclosporine in p-HEMA gels prepared with the same methods as here was previously reported to be 1.44 × 10 −14 m 2 /s [35] . This model however assumes that the initial drug concentration is below the solubility limit in the gel. It is clear that if the initial loading in the gel is increased above a threshold corresponding to the drug solubility inside the gel matrix, the excess drug will form particles inside the polymer matrix as illustrated in Fig. 3 . When the drug concentration is below a threshold limit inside the gel matrix, most of the drug is bound to the polymer (Fig. 3A) . As the polymer matrix reaches saturation, drug aggregates start forming inside the hydrogel (Fig. 3B ) and after further loading of the drug, the concentration of drug present as aggregates far exceeds the drug concentration bound to the polymer matrix (Fig. 3C ). On soaking of this gel in PBS solution, free drug and the adsorbed drug would diffuse out from the gel into the release medium. This transport would then reduce the free drug concentration in the gel matrix leading to breakup of the drug aggregates to compensate for the drug loss. This mechanism results in creation of a depletion zone near the surface which does not contain drug aggregates because these are already dissolved, and the thickness of this zone (δ) increases with time. The free concentration of the drug in the zone that still contains the drug aggregates must be equal to the solubility concentration (C S ), and the drug contained in the aggregates should be at concentration C A = C TOTAL -C S , where C TOTAL is the initial drug concentration. Thus, we get the following model to describe drug transport from gel systems when the loading is above the solubility limit of the drug in the gel matrix,
with the following initial and boundary conditions,
In the above equations C is the concentration of the un-aggregated drug molecules, which includes both free and polymer bound drug. The first boundary condition (Eq. (5)) assumes perfect sink conditions, the second boundary condition (Eq. (6)) arises from continuity of concentration and the third condition (Eq. (7)) states that the drug flux at the intersection of the zone with drug aggregates and the one without drug aggregates is equal to the amount released by the dissolution of the aggregates. The above model is only valid till δ is less than h, and after that the transport is purely diffusive.
Amount of drug release under the limit
where A is the surface area of the polymer gel and t is the time of release. If the above limit is satisfied, the value of C A would be equal to the total drug concentration initially loaded into the gel (C TOTAL ). Thus, the percentage drug release (%) from the system can then be given by, 
Model validation
To validate the model developed above, it was decided to explore the effect of initial drug loading on release rates of the drug from the p-HEMA gels. Release was conducted in 3.5 ml PBS with PBS replaced every day and the drug loading was varied from 0.125% to 5% inside the gel matrix and the thickness of the gel was kept constant at 200 μm. Data from all the experiments is plotted in Fig. 4 and we observe that the release varies in all the systems as expected. In Fig. 5 , the percentage release is than plotted against ≡ γ t CTOTAL . The release curves overlap for higher drug loadings while there is a clear deviation from the model as the amount of drug loaded inside the hydrogel is reduced below the solubility limit of the drug in the p-HEMA matrix. This is expected since as the drug concentration is decreased inside the gel matrix, the approximation ≫ 1
starts to fail and Eq. (10) is not valid anymore. The slope from the data with higher drug loadings represents Increasing Drug Concentration A B C Fig. 3 . A schematic of drug interaction with the p-HEMA matrix as drug loading is increased. A) Drug loading is below the solubility limit and most of the drug is adsorbed on the polymer matrix. B) As the drug loading is increased beyond the solubility limit of the drug in the hydrogel matrix, drug starts to precipitates and forms aggregates inside the hydrogel. C) At a very high drug loading, concentration of drug aggregates is much higher than the concentration of polymer bound drug. /s), we can determine the solubility, C S , of the drug in the p-HEMA matrix to be 3 mM. Based on the measured value of 20 μM for the solubility limit of CyA in PBS, the partition coefficient at the solubility limit is which is determined to be 150, which agrees with the values 148 ± 24.16 measured at the lower concentrations. This shows that the partition coefficient of the drug cyclosporine is independent of concentration even at the solubility limit, which implies that the pHEMA polymer has a very high capacity for the drug and so the surface of the polymer is not saturated. The release profiles clearly show that as expected the duration of the drug release from a gel can be significantly altered once the drug forms aggregates inside the hydrogel and thus, desired release rates of the drug can be achieved by loading varying amount of drug inside contact lenses.
Theoretical model for diffusivity estimation
Brinkman combined Darcy's law and Navier-Stokes equation to determine an expression for force acting on a particle moving through a viscous medium [42] . Phillips et al. confirmed validity of using Brinkman's equation for solute diffusion through a porous medium by both experimental and Stokesian dynamics [43] . These models can be used to estimate diffusivity of molecules in hydrogels,
where, D TH is the theoretically determined diffusivity of the molecule inside the gel (=D f , see Eq. (12)), r is the solute radius, k is the hydraulic permeability of the medium, μ is the viscosity of water, T is the temperature and k B is the Boltzmann's constant. Later it was suggested that Eq. (11) is valid only if there is a pressure driven flow and to correct for the absence of pressure, the coefficient of r 2 /k should be 1/9
instead of 1/3 [44] . Thus for evaluating the theoretical diffusivity for our systems, we should use a modified Eq. (11) with 1/3 replaced by 1/ 9. Values of various parameters needed for evaluating the theoretical diffusivity are listed in Table 1 and the value of the diffusivity is determined to be, 5.6 × 10 −12 m 2 /s. This value is clearly significantly higher than the measured effective diffusivity of 1.44 × 10 −14 m 2 /s.
These differences however can be rationalized by noting that the drug in the hydrogel is mainly adsorbed on the polymer, while Eq. (11) is the estimate based on a free molecule. Drug molecules in the gel exist either as free dissolved state in the aqueous pores in the gel or adsorbed on the polymer. The effective diffusivity thus can be defined as,
where, D f is the diffusivity of the drug in the solution inside the gel, D SU is the surface diffusivity of the drug on the gel surface, f is the fraction of water taken up by the hydrogel which is 0.4 for p-HEMA gels [45] and K is the partition coefficient determined in Section 3.1 to be 148. It is possible that there is negligible surface diffusivity for CyA and so if we assume D SU to be 0 than D f can be evaluated from Eq. (12) to be 5.33 × 10 −12 m 2 /s. This value is similar to that evaluated from the Brinkman model for solute diffusivity in porous medium suggesting that hydrodynamic interactions of the polymer matrix with the drug molecule has a significant contribution in molecular transport from p-HEMA gels. This also suggests that surface diffusivity for CyA inside the gel matrix is negligible and based on the structural information of the system such as the hydraulic permeability of the gel and solute radius we can determine the effective diffusivity of drugs from p-HEMA gels.
Effect of drug concentration on transparency
The results from the release studies clearly show that it is possible to achieve the release duration from gels by controlling the concentration of the drug because drug in excess of solubility limit forms particles. These particles could however reduce the clarity of the gels, which would be a big drawback for contact lenses. The transmittance of the gels were measured to determine the suitability of these gels as contact lenses. Results in Fig. 6 show that gels maintained the transparency if the drug loading in the gel was kept below 0.4%, which is the close to the solubility limit of the drug in the gel. As drug concentration was increased thereafter, gels started to turn hazy with 5.25% CyA loaded gels being almost opaque. Fig. 7 shows the SEM images of the nontransparent (concentration > 0.125%) 200 μm thick gels. Fig. 7 shows that the drug forms large particles at concentrations of 0.125% and larger, which would scatter visible light reducing the transparency. 
% CyA Loading
Transmittance (%) Fig. 6 . Effect of the drug loading on the transmittance of the gel at 600 nm wavelength.
Transmittance values start to go down as the drug loading inside the hydrogel reaches the solubility limit.
Conclusion
The results here prove that the drug release duration of hydrophobic drugs can easily be tailored by varying the initial drug loading. However this approach does not appear to be promising for contact lenses due to the loss of transparency. The loss of transparency is clearly due to scattering of the visible light by the drug particles in the gels. The scattering can be minimized by reducing the particle size to less than the wavelength of the visible light. It may be possible to control the particle size by varying the rates of polymerization. For instance, if polymerization is very rapid, drug molecules will diffuse short distances before getting trapped so the particle size would likely be small. Even in these scenario though, the size could grow slowly due to Oswald ripening. The rates of Oswald ripening have not been measured in gels so this could be an interesting study for the future. There are some other challenges as well including extraction of the unreacted monomer, sterilization, and storage. The unreacted monomer must be removed to avoid toxicity but drug can diffuse out during that process. Extraction of the unreacted monomer will be particularly challenging because cyclosporine has a high solubility in the organic liquids used in the extraction process. However, due to the long release duration, only a small fraction will be extracted so the remaining fraction will redistribute in the lens during packaging. The duration of release is significantly longer than the typical autoclaving duration of about an hour. So it would be feasible to sterilize by autoclaving, particularly for hydrophobic drugs with low water solubility. Storing will also not be an issue because the drug loss in the small storage volume will not be significant for the hydrophobic drugs. Additionally, impact of the particle loading on mechanical properties and cytotoxicity must be considered. These issues however are important and will be explored in future. 
